A new report indicates that sales of new blood-thinning medication Eliquis are gaining on those of Xarelto, the long-time leader in the industry. For decades, if you needed a blood thinner because you suffered from a serious medical condition known as atrial fibrillation (Afib), you would take a a drug like warfarin…
A recent article from Cleveland.com takes a look at how drug companies may be manipulating potential patients by asking them to speak to their doctors about a particular drug. This is actually a fairly contentious issue, as drug companies formerly were not able to market directly to patients through television…
According to a recent news feature from Fierce Pharma, Bristol-Myers Squibb (BMY) has reported huge profits over the past fiscal quarter. Their immuno-oncology division had released a drug known as Opodivo that earned $475 million in last quarter alone, but much of the company’s success also comes from a drug…
New Oral Anticoagulants (NOACs) are big money for drug companies and marketing partners pushing four different medications currently on the market. One of the four drugs is Eliquis, manufactured by Bristol-Myers Squibb (BMS), and, according to recent article from Forbes, the drugmaker has a lot riding on Eliquis sales. Specifically,…
For decades, Warfarin (Coumadin) has been the gold standard drug for atrial fibrillation (Afib) patients to avoid being at a higher risk for stroke and other potentially deadly medical conditions like a pulmonary embolism (PE). While Warfarin is considered relatively safe, it does require patients to have frequent monitoring by…
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. Based upon a recent study, paid for by BMS and Pfizer, their drug, Eliquis, was shown…
The manufacturer of Eliquis is now claiming there has been a reduction in deaths for Afib patients who take the anticoagulant medication, but a review at the United States Food and Drug Administration is questioning this allegation, according to a recent news article from the Journal Sentinel. Eliquis is one…
Xarelto is an anticoagulant medication manufactured by Bayer AG, the German pharmaceutical giant, and Janssen, a subsidiary of Johnson & Johnson, markets it in the United States. Xarelto is one of three relatively new forms of medication marketed to treat patients who suffer from a condition known as atrial fibrillation…
While Bayer AG, the German pharmaceutical giant, has seen a recent increase in quarter-over-quarter profits, sales numbers for their bestselling drug, Xarelto, have actually dropped this past quarter for the first time since the United States Food and Drug Administration (FDA) approved it for market. Xarelto is a member of…
According to a recent news feature from the Madison Record, a woman in Texas is suing Bayer Pharmaceuticals AG, and its United States marketing partner Janssen Pharmaceuticals (Johnson & Johnson) for injuries she alleges was a result of her Xarelto prescription. Xarelto is the brand name for a drug known…